Estrogen upregulation of BRCA1 expression with no effect on localization

Donato Romagnolo, Lois A. Annab, Tracy E. Thompson, John I. Risinger, Lori A. Terry, J. Carl Barrett, Cynthia A. Afshari

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Alterations in the expression of the breast and ovarian cancer susceptibility gene BRCA1 may contribute to the development of mammary and ovarian neoplasia. The sex-steroid estrogen modulates cell proliferation of normal and neoplastic breast and ovarian epithelial cells, but the role of estrogen regulation on the expression of BRCA1 remains to be defined. In this study, estrogen-regulated BRCA1 expression was examined in breast and ovarian cancer cells. Estrogen stimulated the proliferation of estrogen receptor (ER)-positive breast MCF-7, C7-MCF-7, and ovarian BG-1 cells as well as the expression of the estrogen-inducible pS2 gene. This was concomitant with upregulation of BRCA1 mRNA (2.5- to 5.0-fold) and a 3- to 10-fold induction of BRCA1 protein (230 kDa). Cell fractionation studies localized the BRCA1 protein to the nucleus in both unstimulated and estrogen-stimulated cells. The antiestrogen ICI-182780 inhibited estrogen-induced cell proliferation, BRCA1 mRNA induction, and BRCA1 protein expression in ER-positive cells. Conversely, estrogen did not influence expression of BRCA1 in HBL-100 cells that lacked the estrogen receptor, although the constitutive levels of BRCA1 mRNA (but not protein) in these cells were 5- to 30-fold higher than in other breast and ovarian cancer cells. Secretion of the BRCA1 protein into the cell medium did not account for the discrepancy between the mRNA and protein levels in HBL-100 cells. Proliferation of HBL-100 cells was not affected by either estrogen or ICI-182780. Taken together, these data support a role for the steroid estrogen and the involvement of the estrogen receptor pathway in the modulation of expression of BRCA1. We therefore propose that stimulation of cell proliferation may be a prerequisite for upregulation of BRCA1 in breast and ovarian cancer cells.

Original languageEnglish (US)
Pages (from-to)102-109
Number of pages8
JournalMolecular Carcinogenesis
Volume22
Issue number2
DOIs
StatePublished - Jun 1998

Fingerprint

Estrogens
Up-Regulation
BRCA1 Protein
Estrogen Receptors
Ovarian Neoplasms
Breast Neoplasms
Messenger RNA
Breast
Cell Proliferation
Steroids
Cell Fractionation
Estrogen Receptor Modulators
Neoplasm Genes
Proteins
Epithelial Cells
Genes

Keywords

  • BRCA1
  • Breast cancer
  • Hormone
  • Ovarian cancer

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology

Cite this

Romagnolo, D., Annab, L. A., Thompson, T. E., Risinger, J. I., Terry, L. A., Barrett, J. C., & Afshari, C. A. (1998). Estrogen upregulation of BRCA1 expression with no effect on localization. Molecular Carcinogenesis, 22(2), 102-109. https://doi.org/10.1002/(SICI)1098-2744(199806)22:2<102::AID-MC5>3.0.CO;2-O

Estrogen upregulation of BRCA1 expression with no effect on localization. / Romagnolo, Donato; Annab, Lois A.; Thompson, Tracy E.; Risinger, John I.; Terry, Lori A.; Barrett, J. Carl; Afshari, Cynthia A.

In: Molecular Carcinogenesis, Vol. 22, No. 2, 06.1998, p. 102-109.

Research output: Contribution to journalArticle

Romagnolo, Donato ; Annab, Lois A. ; Thompson, Tracy E. ; Risinger, John I. ; Terry, Lori A. ; Barrett, J. Carl ; Afshari, Cynthia A. / Estrogen upregulation of BRCA1 expression with no effect on localization. In: Molecular Carcinogenesis. 1998 ; Vol. 22, No. 2. pp. 102-109.
@article{0584dd347acc49f6acc806ea166b4199,
title = "Estrogen upregulation of BRCA1 expression with no effect on localization",
abstract = "Alterations in the expression of the breast and ovarian cancer susceptibility gene BRCA1 may contribute to the development of mammary and ovarian neoplasia. The sex-steroid estrogen modulates cell proliferation of normal and neoplastic breast and ovarian epithelial cells, but the role of estrogen regulation on the expression of BRCA1 remains to be defined. In this study, estrogen-regulated BRCA1 expression was examined in breast and ovarian cancer cells. Estrogen stimulated the proliferation of estrogen receptor (ER)-positive breast MCF-7, C7-MCF-7, and ovarian BG-1 cells as well as the expression of the estrogen-inducible pS2 gene. This was concomitant with upregulation of BRCA1 mRNA (2.5- to 5.0-fold) and a 3- to 10-fold induction of BRCA1 protein (230 kDa). Cell fractionation studies localized the BRCA1 protein to the nucleus in both unstimulated and estrogen-stimulated cells. The antiestrogen ICI-182780 inhibited estrogen-induced cell proliferation, BRCA1 mRNA induction, and BRCA1 protein expression in ER-positive cells. Conversely, estrogen did not influence expression of BRCA1 in HBL-100 cells that lacked the estrogen receptor, although the constitutive levels of BRCA1 mRNA (but not protein) in these cells were 5- to 30-fold higher than in other breast and ovarian cancer cells. Secretion of the BRCA1 protein into the cell medium did not account for the discrepancy between the mRNA and protein levels in HBL-100 cells. Proliferation of HBL-100 cells was not affected by either estrogen or ICI-182780. Taken together, these data support a role for the steroid estrogen and the involvement of the estrogen receptor pathway in the modulation of expression of BRCA1. We therefore propose that stimulation of cell proliferation may be a prerequisite for upregulation of BRCA1 in breast and ovarian cancer cells.",
keywords = "BRCA1, Breast cancer, Hormone, Ovarian cancer",
author = "Donato Romagnolo and Annab, {Lois A.} and Thompson, {Tracy E.} and Risinger, {John I.} and Terry, {Lori A.} and Barrett, {J. Carl} and Afshari, {Cynthia A.}",
year = "1998",
month = "6",
doi = "10.1002/(SICI)1098-2744(199806)22:2<102::AID-MC5>3.0.CO;2-O",
language = "English (US)",
volume = "22",
pages = "102--109",
journal = "Molecular Carcinogenesis",
issn = "0899-1987",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Estrogen upregulation of BRCA1 expression with no effect on localization

AU - Romagnolo, Donato

AU - Annab, Lois A.

AU - Thompson, Tracy E.

AU - Risinger, John I.

AU - Terry, Lori A.

AU - Barrett, J. Carl

AU - Afshari, Cynthia A.

PY - 1998/6

Y1 - 1998/6

N2 - Alterations in the expression of the breast and ovarian cancer susceptibility gene BRCA1 may contribute to the development of mammary and ovarian neoplasia. The sex-steroid estrogen modulates cell proliferation of normal and neoplastic breast and ovarian epithelial cells, but the role of estrogen regulation on the expression of BRCA1 remains to be defined. In this study, estrogen-regulated BRCA1 expression was examined in breast and ovarian cancer cells. Estrogen stimulated the proliferation of estrogen receptor (ER)-positive breast MCF-7, C7-MCF-7, and ovarian BG-1 cells as well as the expression of the estrogen-inducible pS2 gene. This was concomitant with upregulation of BRCA1 mRNA (2.5- to 5.0-fold) and a 3- to 10-fold induction of BRCA1 protein (230 kDa). Cell fractionation studies localized the BRCA1 protein to the nucleus in both unstimulated and estrogen-stimulated cells. The antiestrogen ICI-182780 inhibited estrogen-induced cell proliferation, BRCA1 mRNA induction, and BRCA1 protein expression in ER-positive cells. Conversely, estrogen did not influence expression of BRCA1 in HBL-100 cells that lacked the estrogen receptor, although the constitutive levels of BRCA1 mRNA (but not protein) in these cells were 5- to 30-fold higher than in other breast and ovarian cancer cells. Secretion of the BRCA1 protein into the cell medium did not account for the discrepancy between the mRNA and protein levels in HBL-100 cells. Proliferation of HBL-100 cells was not affected by either estrogen or ICI-182780. Taken together, these data support a role for the steroid estrogen and the involvement of the estrogen receptor pathway in the modulation of expression of BRCA1. We therefore propose that stimulation of cell proliferation may be a prerequisite for upregulation of BRCA1 in breast and ovarian cancer cells.

AB - Alterations in the expression of the breast and ovarian cancer susceptibility gene BRCA1 may contribute to the development of mammary and ovarian neoplasia. The sex-steroid estrogen modulates cell proliferation of normal and neoplastic breast and ovarian epithelial cells, but the role of estrogen regulation on the expression of BRCA1 remains to be defined. In this study, estrogen-regulated BRCA1 expression was examined in breast and ovarian cancer cells. Estrogen stimulated the proliferation of estrogen receptor (ER)-positive breast MCF-7, C7-MCF-7, and ovarian BG-1 cells as well as the expression of the estrogen-inducible pS2 gene. This was concomitant with upregulation of BRCA1 mRNA (2.5- to 5.0-fold) and a 3- to 10-fold induction of BRCA1 protein (230 kDa). Cell fractionation studies localized the BRCA1 protein to the nucleus in both unstimulated and estrogen-stimulated cells. The antiestrogen ICI-182780 inhibited estrogen-induced cell proliferation, BRCA1 mRNA induction, and BRCA1 protein expression in ER-positive cells. Conversely, estrogen did not influence expression of BRCA1 in HBL-100 cells that lacked the estrogen receptor, although the constitutive levels of BRCA1 mRNA (but not protein) in these cells were 5- to 30-fold higher than in other breast and ovarian cancer cells. Secretion of the BRCA1 protein into the cell medium did not account for the discrepancy between the mRNA and protein levels in HBL-100 cells. Proliferation of HBL-100 cells was not affected by either estrogen or ICI-182780. Taken together, these data support a role for the steroid estrogen and the involvement of the estrogen receptor pathway in the modulation of expression of BRCA1. We therefore propose that stimulation of cell proliferation may be a prerequisite for upregulation of BRCA1 in breast and ovarian cancer cells.

KW - BRCA1

KW - Breast cancer

KW - Hormone

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=0031806108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031806108&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2744(199806)22:2<102::AID-MC5>3.0.CO;2-O

DO - 10.1002/(SICI)1098-2744(199806)22:2<102::AID-MC5>3.0.CO;2-O

M3 - Article

VL - 22

SP - 102

EP - 109

JO - Molecular Carcinogenesis

JF - Molecular Carcinogenesis

SN - 0899-1987

IS - 2

ER -